Search

Your search keyword '"Da Costa, Alexandre Andre B. A."' showing total 16 results
Start Over Author "Da Costa, Alexandre Andre B. A."
16 results on '"Da Costa, Alexandre Andre B. A."'

1. Abstract 5725: The USP1 inhibitor I-138 kills BRCA1-deficient tumor cells and overcomes PARP inhibitor resistance

Author

Da Costa, Alexandre Andre B. A., primary, Bose, Arindam, additional, Martignetti, David, additional, Ayala-Zambrano, Cecilia, additional, Ravindranathan, Ramya, additional, Sadatrezaei, Golbahar, additional, Jiao, Yuqing, additional, Kochupurakkal, Bose, additional, Nguyen, Huy, additional, Lazaro, Jean-Bernard, additional, Parmar, Kalindi, additional, Shapiro, Geoffrey I., additional, and D’Andrea, Alan D., additional

Published
2023
Full Text
View/download PDF

3. Association of time interval from neoadjuvant chemotherapy to interval cytoreduction and interval cytoreduction to adjuvant chemotherapy with survival outcomes and risk of platinum resistance.

Author

Alencar, Viviane, primary, Pirolli, Rafaela, additional, Estati, Felipe Leonardo, additional, Ribeiro, Adriana Regina Goncalves, additional, Guimaraes, Andrea Paiva, additional, Baiocchi, Glauco, additional, and Da Costa, Alexandre Andre B. A., additional

Published
2020
Full Text
View/download PDF

4. Influence of BRCA pathogenic variants in the benefit of secondary cytoreductive surgery.

Author

Estati, Felipe Leonardo, primary, Alencar, Viviane, additional, Pirolli, Rafaela, additional, Ribeiro, Adriana Regina Goncalves, additional, Torrezan, Giovana Tardin, additional, Carraro, Dirce Maria, additional, Formiga, Maria Nirvana, additional, Guimaraes, Andrea Paiva, additional, Baiocchi, Glauco, additional, and Da Costa, Alexandre Andre B. A., additional

Published
2020
Full Text
View/download PDF

5. Comparison of enzalutamide versus abiraterone in castration-resistant prostate cancer before docetaxel: Results of a propensity score-matched analysis.

Author

Cesca, Marcelle Goldner, primary, Silveira, Maysa Tamara, additional, Pandolfi, Natasha Carvalho, additional, Oliveira, Thiago Bueno, additional, Rinck, José Augusto, additional, Da Costa, Alexandre Andre B. A., additional, Corassa, Marcelo, additional, Formiga, Maria Nirvana, additional, and Dettino, Aldo A., additional

Published
2019
Full Text
View/download PDF

8. Adjuvant radiation therapy in patients with breast cancer and Li-Fraumeni syndrome: Oncologic results and incidence of second neoplasms.

Author

Gondim, Guilherme Rocha Melo, primary, Formiga, Maria Nirvana Cruz, additional, Castro, Douglas Guedes, additional, Silva, Maria Leticia GOBO, additional, .Chen, Michael, additional, Fogaroli, Ricardo, additional, Ramos, Henderson, additional, Coelho, Tharcisio Machado, additional, Pellizzon, Antonio Cassio Assis, additional, and Da Costa, Alexandre Andre B. A., additional

Published
2018
Full Text
View/download PDF

9. Interval between last neoadjuvant chemotherapy and surgery and between surgery and first adjuvant chemotherapy in ovarian cancer patients.

Author

Da Costa, Alexandre Andre B. A., primary, Ribeiro, Adriana Regina Goncalves, additional, Mantoan, Henrique, additional, Stecca, Carlos, additional, Santana dos Santos, Elizabeth, additional, Lima, Joao Paulo, additional, Oliveira, Audrey, additional, Cotrim, Deborah Porto, additional, Grapp, Larissa Von, additional, Ramos Sousa, Victor Aurelio, additional, Maia, Joyce Maria L., additional, Guimaraes, Andrea Paiva, additional, and Baiocchi, Glauco, additional

Published
2018
Full Text
View/download PDF

10. PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).

Author

Da Costa, Alexandre Andre B. A., primary, Costa, Felipe D'Almeida, additional, de Oliveira, Andrea Cruz Ferraz, additional, Stecca, Carlos, additional, Oliveira, Audrey, additional, Alves, Ana Caroline Fonseca, additional, Camandaroba, Marcos Pedro Guedes, additional, Araujo, Daniel Vilarim, additional, Machado, Larissa, additional, and Cordeiro De Lima, Vladmir Claudio, additional

Published
2017
Full Text
View/download PDF

15. Randomized phase 2 study of gemcitabine with or without ATR inhibitor berzosertib in platinum-resistant ovarian cancer: Final overall survival (OS) and biomarker analyses.

Author

Konstantinopoulos, Panagiotis A., Lee, Elizabeth Katherine, Cheng, SuChun, Da Costa, Alexandre Andre B. A., Wahner Hendrickson, Andrea Elisabeth, Gulhan, Doga, Kochupurakkal, Bose, Kolin, David, Kohn, Elise C., Liu, Joyce F., Stover, Elizabeth, Curtis, Jennifer, Sawyer, Hannah, Polak, Madeline, Chowdhury, Dipanjan, Färkkilä, Anniina, D'Andrea, Alan D., Shapiro, Geoffrey, and Matulonis, Ursula A.

Published
2023
Full Text
View/download PDF

16. Regarding "Immunotherapy in locally advanced cervix cancer: A critical appraisal of the FDA indication based on ENGOT-CX11/GOG-3047/KEYNOTE-A18".

Author

da Costa AABA, Souza RP, Pandolfi NC, de Souza Castro F, Baiocchi G, and Guimarães APG

Subjects
Humans, Female, United States, Immunotherapy methods, Immune Checkpoint Inhibitors therapeutic use, Uterine Cervical Neoplasms therapy, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms drug therapy, Uterine Cervical Neoplasms immunology, United States Food and Drug Administration
Abstract

Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Fabrício de Souza Castro declares no conflict of interests. Alexandre Andre B A da Costa declares no conflict of itnerests. Andrea Paiva G Guimaraes declares no conflict of interests Natasha Carvalho Pandolfi declares no conflict of interests. Ronaldo Pereira Souza declares no conflict of interests. Glauco Baiocchi declares honoraria and consulting from Astra Zeneca, GSK and MSD.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results